Hand, foot, and mouth disease in children is a highly transmissible viral infection, particularly in young ones. Fever is the ...

Expects submission of EMPAVELI sNDA for C3G and primary IC-MPGN in early 2025; U.S. launch anticipated in 2H 2025, if approved Plans initiation of Phase 3 studies of pegcetacoplan in two additional ...

VIVUS will be discussing its significant 2024 momentum during the J.P. Morgan Healthcare Conference, with an emphasis on what we as a company aim to achieve during the coming months around our novel ...

In this article, we will look at the effects of biotin pills for hair growth, how to give your hair a natural shine, and the ...

Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...

Harmony Biosciences Holdings, Inc. today announced strong preliminary, unaudited net product revenues for Q4 and full year 2024 of $201 million and $714 million, respectively. Building on this ...

Novocure today reported preliminary unaudited financial and operational results for the quarter and full year ended December 31, 2024. Novocure is a global oncology company working to extend survival ...

Cycle Pharmaceuticals, Inc. (Cycle) announces today completion of the acquisition of Banner Life Sciences, LLC (Banner) which includes its BAFIERTAM ® (monomethyl fumarate) product for the treatment ...

BBC Morning Live's regular medical expert Dr Ranj has shared a stark warning that sepsis may be mistaken for common ...

A regular guest on BBC Morning Live has warned that a severe and life-threatening illness may be mistaken for flu, or a ...

NDAQ:KNSA) Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance ...